The oral combination of thalidomide, cyclophosphamide and dexamethasone (ThaCyDex) is effective in relapsed/refractory multiple myeloma.
García-Sanz R, González-Porras JR, Hernández JM, Polo-Zarzuela M, Sureda A, Barrenetxea C, Palomera L, López R, Grande-García C, Alegre A, Vargas-Pabón M, Gutiérrez ON, Rodríguez JA, San Miguel JF.
García-Sanz R, et al.
Leukemia. 2004 Apr;18(4):856-63. doi: 10.1038/sj.leu.2403322.
Leukemia. 2004.
PMID: 14973508
Clinical Trial.